Clinical Trial Update: MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

MITO-5 is a Phase 2 trial evaluating weekly carboplatin and paclitaxel as first-line chemotherapy for elderly patients with ovarian cancer. The study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED